Market Tracker

08/22 6:05pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

90.22
Data as of Aug 22
 +1.23 / +1.38%
Today’s Change
58.06
Today|||52-Week Range
99.74
+21.43%
Year-to-Date

Today’s Trading

Previous close88.99
Today’s open89.50
Day’s range88.67 - 90.63
Volume862,435
Average volume (3 months)2,109,149
Market cap$21.5B
Dividend yield--
Data as of 3:59pm ET, 08/22/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-46.42%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book15.55

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+1.47+0.99%
MYLMylan Inc+0.46+0.96%
ZTSZoetis Inc0.000.00%
BMRNBiomarin Pharmaceuti...+0.79+1.14%
Data as of 4:02pm ET, 08/22/2014

Financials

Next reporting dateOctober 27, 2014
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts